troglitazone has been researched along with Neutropenia in 1 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Whitcomb, RW | 1 |
1 other study available for troglitazone and Neutropenia
| Article | Year |
|---|---|
Update in endocrinology.
Topics: Chromans; Humans; Hypoglycemic Agents; Liver Failure; Neutropenia; Thiazoles; Thiazolidinediones; Tr | 1998 |